| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |